ATE478145T1 - Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren - Google Patents
Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäurenInfo
- Publication number
- ATE478145T1 ATE478145T1 AT00916675T AT00916675T ATE478145T1 AT E478145 T1 ATE478145 T1 AT E478145T1 AT 00916675 T AT00916675 T AT 00916675T AT 00916675 T AT00916675 T AT 00916675T AT E478145 T1 ATE478145 T1 AT E478145T1
- Authority
- AT
- Austria
- Prior art keywords
- polypeptides
- secreted
- nucleic acids
- present
- acids coding
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Emergency Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/012252 WO1999063088A2 (en) | 1998-06-02 | 1999-06-02 | Membrane-bound proteins and nucleic acids encoding the same |
US14103799P | 1999-06-23 | 1999-06-23 | |
US14304899P | 1999-07-07 | 1999-07-07 | |
US14475899P | 1999-07-20 | 1999-07-20 | |
US14569899P | 1999-07-26 | 1999-07-26 | |
US14622299P | 1999-07-28 | 1999-07-28 | |
US14939699P | 1999-08-17 | 1999-08-17 | |
PCT/US1999/021547 WO2000015797A2 (en) | 1998-09-17 | 1999-09-15 | Compositions and methods for the treatment of immune related diseases |
PCT/US1999/021090 WO2000015796A2 (en) | 1998-09-16 | 1999-09-15 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US15866399P | 1999-10-08 | 1999-10-08 | |
PCT/US1999/028313 WO2000032221A2 (en) | 1998-12-01 | 1999-11-30 | Promotion or inhibition of angiogenesis and cardiovascularization |
PCT/US1999/028301 WO2000032776A2 (en) | 1998-12-01 | 1999-12-01 | Secreted amd transmembrane polypeptides and nucleic acids encoding the same |
PCT/US1999/030095 WO2000037640A2 (en) | 1998-12-22 | 1999-12-16 | Compositions and methods for the treatment of tumor |
PCT/US2000/000219 WO2000053753A2 (en) | 1999-03-08 | 2000-01-05 | Promotion or inhibition of angiogenesis and cardiovascularization |
PCT/US2000/000376 WO2000053755A2 (en) | 1999-03-08 | 2000-01-06 | Compositions and methods for the treatment of tumor |
PCT/US2000/003565 WO2001053486A1 (en) | 1999-03-08 | 2000-02-11 | Compositions and methods for the treatment of tumor |
PCT/US2000/004341 WO2000053756A2 (en) | 1999-03-08 | 2000-02-18 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/004414 WO2001004311A1 (en) | 1999-07-07 | 2000-02-22 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
PCT/US2000/004914 WO2000075327A1 (en) | 1999-06-02 | 2000-02-24 | Methods and compositions for inhibiting neoplastic cell growth |
PCT/US2000/005841 WO2000053758A2 (en) | 1999-03-08 | 2000-03-02 | Compositions and methods for the treatment of immune related diseases |
PCT/US2000/006884 WO2001005972A1 (en) | 1999-07-20 | 2000-03-15 | Compositions and methods for the treatment of immune related diseases |
PCT/US2000/007377 WO2001019991A1 (en) | 1999-09-15 | 2000-03-20 | Compositions and methods for the treatment of immune related diseases |
PCT/US2000/008439 WO2000073454A1 (en) | 1999-06-02 | 2000-03-30 | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE478145T1 true ATE478145T1 (de) | 2010-09-15 |
Family
ID=42676646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00916675T ATE478145T1 (de) | 1999-06-02 | 2000-03-30 | Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1210418B1 (de) |
JP (4) | JP2004522402A (de) |
AT (1) | ATE478145T1 (de) |
AU (1) | AU3774300A (de) |
CA (1) | CA2383254A1 (de) |
WO (1) | WO2000073454A1 (de) |
Families Citing this family (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5773252A (en) | 1995-06-05 | 1998-06-30 | Human Genome Sciences, Inc. | Fibroblast growth factor 15 |
JP2001514885A (ja) | 1997-08-19 | 2001-09-18 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 70個のヒト分泌タンパク質 |
US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
WO1999040189A2 (en) | 1998-02-09 | 1999-08-12 | Genset | Cdnas encoding secreted proteins |
US7291712B2 (en) | 1998-06-25 | 2007-11-06 | Genentech, Inc. | Interleukin-8 homologous polypeptides and therapeutic uses thereof |
US7264801B2 (en) | 1998-08-11 | 2007-09-04 | Genentech, Inc. | EG-VEGF nucleic acids and polypeptides and method of use |
US20020172678A1 (en) * | 2000-06-23 | 2002-11-21 | Napoleone Ferrara | EG-VEGF nucleic acids and polypeptides and methods of use |
US20030003507A1 (en) | 1999-06-02 | 2003-01-02 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
DK1109937T3 (da) | 1998-09-02 | 2009-03-09 | Diadexus Inc | Fremgangsmåde til diagnosticering , monitorering, stadiebestemmelse og billeddiagnostisk undersögelse for forskellige cancere |
AU5447899A (en) * | 1998-09-03 | 2000-03-27 | Takeda Chemical Industries Ltd. | Novel protein and process for producing the same |
US7014996B1 (en) | 1998-10-02 | 2006-03-21 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gynecologic cancers |
US6902892B1 (en) | 1998-10-19 | 2005-06-07 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating prostate cancer |
US6468546B1 (en) | 1998-12-17 | 2002-10-22 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
US7888477B2 (en) | 1998-12-17 | 2011-02-15 | Corixa Corporation | Ovarian cancer-associated antibodies and kits |
AU2007216683B2 (en) * | 1998-12-17 | 2011-07-14 | Corixa Corporation | Compositions and methods for therapy and diagnosis of ovarian cancer |
US6962980B2 (en) | 1999-09-24 | 2005-11-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of ovarian cancer |
AU2387900A (en) * | 1998-12-23 | 2000-07-12 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
US7083791B2 (en) | 1999-03-25 | 2006-08-01 | Genesis Research & Development Corporation Limited | Methods for enhancing immune responses by fibroblast growth factor receptor 5 polypeptides |
US6242419B1 (en) * | 1999-03-25 | 2001-06-05 | Genesis Research & Development Corporation Ltd. | Compositions isolated from stromal cells and methods for their use |
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
AU7573000A (en) * | 1999-09-01 | 2001-03-26 | Genentech Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
EP1623991A3 (de) * | 1999-09-01 | 2006-06-07 | Genentech, Inc. | Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure |
WO2001023553A2 (en) * | 1999-09-29 | 2001-04-05 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Metastasis-associated antigen c4.4a |
US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
DE60040240D1 (de) * | 1999-12-23 | 2008-10-23 | Zymogenetics Inc | Löslicher interleukin-20 rezeptor |
US7122632B2 (en) | 1999-12-23 | 2006-10-17 | Zymogenetics, Inc. | Soluble Interleukin-20 receptor |
EP1244784A2 (de) * | 2000-01-06 | 2002-10-02 | Genentech, Inc. | Verfahren und zusammensetzungen zur hemmung des wachstums von neoplastischen zellen |
EP1947182A1 (de) * | 2000-02-15 | 2008-07-23 | Amgen Inc. | Fibroblastenwachstumsfaktor-23-Moleküle und ihre Verwendung |
CA2398603A1 (en) * | 2000-02-15 | 2001-08-23 | Amgen, Inc. | Fibroblast growth factor-23 molecules and uses thereof |
US7135303B2 (en) | 2000-02-28 | 2006-11-14 | The United States Of America As Represented By The Department Of Health And Human Services | Regulators of type-1 tumor necrosis factor receptor and other cytokine receptor shedding |
AU6802801A (en) * | 2000-03-01 | 2001-09-24 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US20020082205A1 (en) * | 2000-03-08 | 2002-06-27 | Nobuyuki Itoh | Human FGF-23 gene and gene expression products |
WO2001066596A2 (en) * | 2000-03-08 | 2001-09-13 | Chiron Corporation | Human fgf-23 gene and gene expression products |
PT1283214E (pt) | 2000-04-21 | 2007-03-30 | Fuso Pharmaceutical Ind | Novas colectinas |
CA2407746A1 (en) * | 2000-05-04 | 2001-11-08 | Incyte Genomics, Inc. | Proteases |
US6897286B2 (en) | 2000-05-11 | 2005-05-24 | Zymogenetics, Inc. | Zsig33-like peptides |
ATE473280T1 (de) * | 2000-05-11 | 2010-07-15 | Zymogenetics Inc | Zsig33-ähnliche peptide |
EP1176200A3 (de) | 2000-06-20 | 2005-01-12 | Switch Biotech Aktiengesellschaft | Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen |
US20020165347A1 (en) * | 2000-06-30 | 2002-11-07 | Amgen, Inc. | B7-like molecules and uses thereof |
DE60128916T2 (de) | 2000-07-18 | 2007-09-20 | Takeda Pharmaceutical Co. Ltd. | Neues, physiologisch aktives peptid und dessen verwendung |
ES2340662T3 (es) | 2000-07-19 | 2010-06-08 | Advanced Research And Technology Institute | Factor de crecimiento de fibroblastos (fgf23) nuevo procedimiento para el uso. |
WO2002014504A1 (fr) * | 2000-08-11 | 2002-02-21 | Kirin Beer Kabushiki Kaisha | Polypeptides de regulation du metabolisme de l'acide phosphorique, du metabolisme du calcium, du metabolisme de la calcification et de la vitamine d et des adn codant pour de tels polypeptides |
EP1341814A2 (de) * | 2000-09-01 | 2003-09-10 | Genentech, Inc. | Sekretierte- und transmembranpolypeptide sowie dafür kodierende nukleinsäuren |
JP2004532609A (ja) | 2000-11-03 | 2004-10-28 | ザ リージェント オブ ザ ユニバーシティ オブ カリフォルニア | プロキネチシンポリペプチド、関連組成物および方法 |
KR20030074678A (ko) * | 2000-12-26 | 2003-09-19 | 추가이 세이야쿠 가부시키가이샤 | 혈중 인농도를 저하시키는 인간 fgf23 단백질 변이체 |
EP1873245A1 (de) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Interleukin-8-homologe Polypeptide und ihre therapeutische Verwendung |
EP1881065A1 (de) * | 2001-03-27 | 2008-01-23 | Novartis AG | DINO Polypeptid |
US6734289B2 (en) * | 2001-03-29 | 2004-05-11 | The University Of Chicago | Gastrokines and derived peptides including inhibitors |
US7033790B2 (en) | 2001-04-03 | 2006-04-25 | Curagen Corporation | Proteins and nucleic acids encoding same |
AU2002318112B2 (en) | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
WO2003002737A1 (fr) * | 2001-06-27 | 2003-01-09 | Riken | Nouvelle proteine inhibitrice de la topoisomerase humaine 2$g(a) et utilisation associee |
CA2453653A1 (en) * | 2001-07-26 | 2003-02-06 | Genset S.A. | Gmg-2 polynucleotides and polypeptides and uses thereof |
WO2005063299A2 (en) * | 2003-12-24 | 2005-07-14 | Genentech, Inc. | Compositions and methods for the treatment of tumor of hematopoietic origin |
ES2331414T3 (es) | 2001-12-28 | 2010-01-04 | Kyowa Hakko Kirin Co Ltd | Anticuerpos contra el factor 23 de crecimiento de fibroblastos. |
EP1530590A2 (de) * | 2002-03-22 | 2005-05-18 | Bioxell S.p.a. | Triggering receptors expressed on myeloid cells (trem)-4 und -5 und deren verwendung |
WO2003090600A2 (en) * | 2002-04-23 | 2003-11-06 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
DE60324797D1 (de) * | 2002-05-31 | 2009-01-02 | Seikagaku Kogyo Co Ltd | Chondroitinsynthetase und das enzym codierende dna |
WO2004022087A1 (ja) * | 2002-09-04 | 2004-03-18 | Takeda Pharmaceutical Company Limited | 疾患関連遺伝子の用途 |
CA2505707A1 (en) * | 2002-11-07 | 2004-05-21 | National Institute Of Advanced Industrial Science And Technology | Method of detecting bone paget's disease |
US8017737B2 (en) | 2002-11-19 | 2011-09-13 | Hasan Kulaksiz | Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
RU2359268C2 (ru) * | 2002-11-19 | 2009-06-20 | ДиАрДжи ИНТЕРНЭШНЛ, ИНК. | Способ диагностики заболеваний путем скрининга тканей, крови или жидкостей организма животных или человека на предмет обнаружения нефизиологических уровней гепсидина и его терапевтическое применение |
US7411048B2 (en) * | 2002-11-19 | 2008-08-12 | Drg International, Inc. | Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids |
DE10254601A1 (de) | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
US7312197B2 (en) | 2003-02-24 | 2007-12-25 | University Of Maryland, Baltimore | Method of modifying glucose activity using polypeptides selectively expressed in fat tissue |
MXPA05009743A (es) | 2003-03-12 | 2006-03-09 | Genentech Inc | Composiciones con actividad hematopoyetica e inmune. |
US20050025763A1 (en) | 2003-05-08 | 2005-02-03 | Protein Design Laboratories, Inc. | Therapeutic use of anti-CS1 antibodies |
US7709610B2 (en) | 2003-05-08 | 2010-05-04 | Facet Biotech Corporation | Therapeutic use of anti-CS1 antibodies |
WO2004106540A1 (en) * | 2003-05-28 | 2004-12-09 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with puromycin-insensitive leucyl-specific aminopeptidase (pils) |
NZ576411A (en) * | 2003-11-17 | 2010-04-30 | Genentech Inc | Compositions and methods for the treatment of tumor of hematopoietic origin |
WO2005068497A1 (en) * | 2004-01-06 | 2005-07-28 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Iis: a novel ifn-gamma-inducible protein, member of the secretoglobin family, that modulates cellular invasion and migration |
DE102004024617A1 (de) | 2004-05-18 | 2005-12-29 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
JP2006034189A (ja) * | 2004-07-28 | 2006-02-09 | National Institute Of Advanced Industrial & Technology | 組織の癌化の検出方法 |
US7544659B2 (en) | 2004-08-13 | 2009-06-09 | Genentech, Inc. | Promotion of axonal regeneration |
EP1790664A1 (de) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs |
WO2007067991A2 (en) | 2005-12-08 | 2007-06-14 | Medarex, Inc. | Human monoclonal antibodies to o8e |
CN100460013C (zh) * | 2006-09-05 | 2009-02-11 | 重庆康卫生物科技有限公司 | 口服重组幽门螺杆菌疫苗及其制备方法 |
US8058014B2 (en) | 2006-09-29 | 2011-11-15 | University Of Maryland, Baltimore | Method of diagnosing or predicting disease states in a subject using omentin 1 and omentin 2 |
US7883705B2 (en) | 2007-02-14 | 2011-02-08 | Kyowa Hakko Kirin Co., Ltd. | Anti FGF23 antibody and a pharmaceutical composition comprising the same |
TWI409276B (zh) | 2007-11-02 | 2013-09-21 | Lilly Co Eli | 抗-海帕西啶(hepcidin)抗體及其用途 |
CN102112489B (zh) | 2008-08-06 | 2014-05-14 | 伊莱利利公司 | 抗-hepcidin-25选择性抗体及其用途 |
EP3216462A3 (de) | 2010-02-26 | 2017-12-20 | Novo Nordisk A/S | Stabile, antikörperhaltige zusammensetzungen |
CA2800188A1 (en) | 2010-05-28 | 2011-12-01 | Novo Nordisk A/S | Stable multi-dose compositions comprising an antibody and a preservative |
WO2013167153A1 (en) | 2012-05-09 | 2013-11-14 | Ganymed Pharmaceuticals Ag | Antibodies useful in cancer diagnosis |
SG11201507429TA (en) | 2013-03-15 | 2015-10-29 | Genentech Inc | Il-22 polypeptides and il-22 fc fusion proteins and methods of use |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5707829A (en) * | 1995-08-11 | 1998-01-13 | Genetics Institute, Inc. | DNA sequences and secreted proteins encoded thereby |
US5824504A (en) * | 1996-09-26 | 1998-10-20 | Elshourbagy; Nabil A. | Human 7-transmembrane receptor and DNA |
WO1999063088A2 (en) * | 1998-06-02 | 1999-12-09 | Genentech, Inc. | Membrane-bound proteins and nucleic acids encoding the same |
WO1998039448A2 (en) * | 1997-03-07 | 1998-09-11 | Human Genome Sciences, Inc. | 186 human secreted proteins |
JP2002512517A (ja) * | 1997-03-25 | 2002-04-23 | ジェネティックス・インスチチュート・インコーポレーテッド | 分泌蛋白およびそれらをコードするポリヌクレオチド |
CA2296287A1 (en) * | 1997-08-01 | 1999-02-11 | Genset | 5' ests for secreted proteins expressed in prostate |
DE19811194A1 (de) * | 1998-03-10 | 1999-09-16 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Prostatagewebe |
DE19817557A1 (de) * | 1998-04-09 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Ovartumorgewebe |
JPH11332571A (ja) * | 1998-05-29 | 1999-12-07 | Taisho Pharmaceut Co Ltd | 新規遺伝子とそれにコードされる蛋白質 |
EP1100914A2 (de) * | 1998-08-03 | 2001-05-23 | Novartis AG | Neue gene, die die hämatopoiese regulieren |
CA2296792A1 (en) * | 1999-02-26 | 2000-08-26 | Genset S.A. | Expressed sequence tags and encoded human proteins |
EP1173456A4 (de) * | 1999-03-01 | 2005-10-12 | Millennium Pharm Inc | Sekretierte proteine und sie kodierende nukleinsäuren |
WO2000070049A2 (en) * | 1999-05-19 | 2000-11-23 | Incyte Genomics, Inc. | Extracellular signaling molecules |
AU1608201A (en) * | 1999-11-16 | 2001-05-30 | Zymogenetics Inc. | Human zven proteins |
WO2001057190A2 (en) * | 2000-02-03 | 2001-08-09 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
-
2000
- 2000-03-30 AU AU37743/00A patent/AU3774300A/en not_active Abandoned
- 2000-03-30 CA CA002383254A patent/CA2383254A1/en not_active Abandoned
- 2000-03-30 AT AT00916675T patent/ATE478145T1/de not_active IP Right Cessation
- 2000-03-30 WO PCT/US2000/008439 patent/WO2000073454A1/en active Search and Examination
- 2000-03-30 EP EP00916675A patent/EP1210418B1/de not_active Expired - Lifetime
- 2000-03-30 JP JP2001500766A patent/JP2004522402A/ja active Pending
-
2002
- 2002-09-25 JP JP2002341509A patent/JP4017507B2/ja not_active Expired - Lifetime
-
2007
- 2007-06-29 JP JP2007172879A patent/JP5512073B2/ja not_active Expired - Lifetime
-
2011
- 2011-06-22 JP JP2011138276A patent/JP2011236224A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1210418A1 (de) | 2002-06-05 |
JP2004522402A (ja) | 2004-07-29 |
EP1210418B1 (de) | 2010-08-18 |
JP4017507B2 (ja) | 2007-12-05 |
JP5512073B2 (ja) | 2014-06-04 |
AU3774300A (en) | 2000-12-18 |
JP2011236224A (ja) | 2011-11-24 |
JP2007302681A (ja) | 2007-11-22 |
JP2004203742A (ja) | 2004-07-22 |
CA2383254A1 (en) | 2000-12-07 |
WO2000073454A1 (en) | 2000-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE478145T1 (de) | Sekretierte und transmembran polypeptide und dafür kodierende nukleinsäuren | |
ATE447583T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
ATE448246T1 (de) | Sekretierte und transmembran-polypeptide sowie nukleinsäuren zu deren kodierung | |
MXPA01002592A (es) | Polipeptidos de transmembrana y secretados y acidos nucleicos que codifican los mismos. | |
WO2001016318A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001040466A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2000053756A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2001068848A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2002008288A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
WO2002024888A3 (en) | Secreted and transmembrane polypeptides and nucleic acids encoding the same | |
KR100468977B1 (ko) | 분비 및 막횡단 폴리펩티드, 및 이를 코딩하는 핵산 | |
ATE417063T1 (de) | Sekretierte transmembranproteine und dafür kodierende nukleinsäuren | |
ATE300553T1 (de) | Sekretiertes polypeptide und dafür kodierende nukleinsäuren | |
DE69932266D1 (de) | Sekretiertes und transmembranes Polypeptid und dafür kodierende Nukleinsäure | |
ATE363537T1 (de) | Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure | |
ATE396201T1 (de) | Ausgeschiedene und transmembranpolypeptide und dafür kodierende nukleinsäure | |
ATE447026T1 (de) | Ausgeschiedene und transmembrane polypeptide und dafür kodierende nukleinsäure | |
ATE321136T1 (de) | Sekretierte und transmembrane polypeptide und dafür kodierende nukleinsäuren | |
DK1241180T3 (da) | Humant A33 antigen-lignende protein og nucleinsyrer, der koder for dette | |
ATE380864T1 (de) | Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure | |
ATE282047T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
ATE291085T1 (de) | Polypeptide und dafür kodierende nukleinsäure | |
DE69824455D1 (de) | PRO241 Polypeptide und dafür kodierende Nukleinsäuren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |